Special report by epic research 26 april 2013
-
Upload
surbhi-jain -
Category
Business
-
view
217 -
download
0
description
Transcript of Special report by epic research 26 april 2013
26th April 2013
DAILY CHARTIST
VIEW
HIGHLIGHTS
A
Highlights
Nifty traded higher and ended in green on Monday.
Nifty Future ended 51.30 points up at 5834.40
Dabur India future sell call hits 1st tg 142.50, low of
140.85 and Bajaj Auto future remained unexecuted.
Buy SUN PHARMA above 802 for targets 810/818 sl
790
Buy ITC above 320 for targets 323/326 with sl 314.
Past Performance:
KotakMahindra hit both tgts.
HCL tech hit both targets
ApolloTyre hit both targets.
Bajaj Auto future hits 1st tg 1805.
Bharti airtel hit both targets
FIANANCIAL technologies hit both targets.
Union bank hit both target.
ICICI BANK HIT BOTH TGTS.
Buy SUN PHARMA above 980.
SUN PHARMA has made flag on 15 min charts.
Currently trading at 979.60.
Investor’s are advised to buy above 980, break out has
come.
Targets are 986/992 and SL at 972
This is an intra day day call as the pattern is forming on
15 min chart
SUN PHARMA – CHANNEL AND FLAG
BUY ABOVE 802 FOR TARGETS 810/818 SL 790
BUY ABOVE 250 FOR TARGETS OF 265/285 SL 235
Buy ITC above 320.
ICICI BANK is making Channel on 15 min chart.
Currently trading at 319.30
Investors’ are advised to buy above 320 for targets
323/326, Breakout has come.
Targets are 323/326 and SL is to be followed 316.
ITC– CHANNEL AND FLAG
BUY ABOVE 320 FOR TARGETS 323/326 SL 316
Disclaimer
The information and view in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.
All Rights Reserved. Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any other information provided by us to/with
anyone which is related directly or indirectly with them. If found so, then Serious Legal Actions can be taken.